# Presentation: 351264

## Center for Scientific Review (CSR)

## National Institutes of Health

- <date/time>

**Office of the Director**

**National Institute**
**on Alcohol Abuse**
**and Alcoholism**

**National Institute**
**of Arthritis and**
**Musculoskeletal**
**and Skin Diseases**

**National Cancer**
**Institute**

**National Institute**
**of Diabetes and**
**Digestive and**
**Kidney Diseases**

**National Institute**
**of Dental and**
**Craniofacial**
**Research**

**National Institute**
**on Drug Abuse**

**National Institute**
**of Environmental **
**Health Sciences**

**National Institute**
**on Aging**

**National Institute**
**of Child Health**
**and Human**
**Development**

**National Institute on**
**Deafness and Other**
**Communication**
**Disorders**

**National Eye**
**Institute**

**National Human**
**Genome Research**
**Institute**

**National Heart,**
**Lung, and Blood**
**Institute**

**National Institute**
**of Mental Health**

**National Institute**
**of Neurological**
**Disorders and**
**Stroke**

**National Institute**
**of General**
**Medical Sciences**

**National Institute**
**of Nursing Research**

**National Library**
**of Medicine**

**Center for **
**Information**
**Technology**

**Center for **
**Scientific Review**

**National Center**
**for Complementary**
**and Alternative**
**Medicine**

**National Institute**
**of Allergy and**
**Infectious Diseases**

**Fogarty**
**International**
**Center**

**National Center**
**for Research**
**Resources**

***National Institutes of Health***

** **
**Clinical Center**

**National Center on **
**Minority Health and**
**Health Disparities**

**National Institute of **
**Biomedical Imaging**
**and Bioengineering**

## Center for Scientific Review (CSR)

- Focal Point for Initial Review at NIH

- Central receipt point for PHS    applications
- Referral to Institutes and to IRGs and Study Sections
- Review of most research and research training applications for scientific merit

## Applications Submitted to NIH

- Approximately  45,000 grant applications are submitted to NIH each year.
- CSR is responsible for the review of over half of these applications.

## CSR Reorganization Initiatives

- Examination and re-organization of CSR study sections based on:
- integration of review activities of NIMH, NIAAA, and NIDA
- alignment of CSR initial review groups and study sections with current trends in science

## CSR Review Divisions

**Division of Molecular **
**and Cellular Mechanisms**
**Donald Schneider, Ph.D.**

**Division of Physiological **
**Systems**
**Michael Martin, Ph.D.**

**Division of Clinical and**
**Population-Based Studies**
**Elliot Postow, Ph.D.**

**Biochemical  Sciences**
**IRG (BCS)**
**Zakir Bengali, Ph.D.**

**Biophysical and Chemical **
**Sciences IRG (BPC)**
**John Bowers, Ph.D.**

**Cell Development and**
**Function IRG (CDF)**
**Marcia Steinberg, Ph.D.**

**Genetic Sciences**
**IRG (GNS)**
**Camilla Day, Ph.D.***

**Immunological Sciences**
**IRG (IMM)**
**Calbert Laing, Ph.D.**

**Infectious Diseases and**
**Microbiology IRG (IDM)**
**Rona Hirschberg, Ph.D.**

**Molecular, Cellular and**
**Developmental **
**Neurosciences IRG (MCDN)**
**Carole Jelsema, Ph.D.**

**Cardiovascular Sciences**
**IRG (CVS))**
**Jeanne Ketley, Ph.D.**

**Endocrinology & Reproductive**
**Sciences IRG (ENR)**
**Sooja Kim, Ph.D.**

**Integrative, Functional**
**& Cognitive Neuroscience**
**IRG  (IFCN)**
**Christine Mellchior, Ph.D.**

**Musculoskeletal & Dental**
**Sciences IRG (MSD)**
**Daniel McDonald, Ph.D.**

**Nutritional and Metabolic**
**Sciences IRG (NMS)**
**Sooja Kim, Ph.D.**

**Pathophysiological**
**Sciences IRG, (PPS)**
**Mustaq Khan, Ph.D.**

**AIDS and Related**
**Research IRG (ARR)**
**Ranga V. Srinivas, Ph.D.**

**Behavioral & Biobehavioral**
**Processes IRG (BBBP)**
**Anita Sostek, Ph.D.**

**Brain Disorders and Clinical**
**Neuroscience IRG (BDCN)**
**Elliot Postow, Ph.D.***

**Oncological  Sciences**
**IRG (ONC)**
**Syed Quadri, Ph.D.**

**Surgery, Radiology, and**
**Bioengineering IRG (SRB)**
**Eileen Bradley, D. Sc.**

***Acting**

**Risk, Prevention and Health**
**Behavior IRG (RPHB)**
**Michael Micklin, Ph.D.**

**Social Sciences, Nursing,**
**Epidemiology and**
**Methods IRG (SNEM)**
**Robert Weller, Ph.D.**

## Number of R01 Applications Reviewed in the Neuroscience Study Sections(10/98 – 10/00 Councils)

**Number of Applications (total = 7015) **

**46.3%**

**16.8%**

**9.3%**

**8.9%**

**8.4%**

**10.2%**

## Percent of R01 Applications Reviewed in the Neuroscience Study Sections Scoring 15th Percentile or Better(10/98 – 10/00 Councils)

**n=538**

**n=189**

**n=78**

**n=58**

**n=83**

**Percent of Applications**** **

**Total         (3251)            (1180)            (655)            (624)              (592)**

## Percent of R01 Applications Reviewed in the Neuroscience Study Sections Scoring 25th Percentile or Better(10/98 – 10/00 Councils)

**n=894**

**n=307**

**n=134**

**n=106**

**n=141**

**Percent of Applications**** **

**Total         (3251)            (1180)            (655)            (624)              (592)**

## Number of R01 Applications Reviewed in the Behavioral and Social Sciences Study Sections(10/99 – 10/00 Councils)

**25.7%**

**17.7%**

**11.2%**

**14.2%**

**9.2%**

**22.0%**

**Number of Applications (total = 2294) **

## Percent of R01 Applications Reviewed in the Behavioral and Social Sciences Study Sections Scoring 15th Percentile or Better(10/99 – 10/00 Councils)

**n=100**

**n=58**

**n=63**

**n=23**

**n=27**

**Percent of Applications**** **

**Total          (590)              (406)            (326)             (257)              (211)**

## Percent of R01 Applications Reviewed in the Behavioral and Social Sciences Study Sections Scoring 25th Percentile or Better(10/99 – 10/00 Councils)

**n=150**

**n=93**

**n=97**

**n=58**

**n=48**

**Percent of Applications**** **

**Total          (590)              (406)            (326)             (257)              (211)**

## Number of R01 Applications Reviewed in AARR7 and AARR8  Study Sections(10/98 – 10/00 Councils)

**38.0%**

**31.7%**

**8.3%**

**11.2%**

**10.7%**

**Number of Applications (total = 410) **

## Percent of R01 Applications Reviewed in AARR7 and AARR8  Study Sections Scoring 15th Percentile or Better(10/98 – 10/00 Councils)

**n=29**

**n=15**

**n=7**

**n=6**

**Total           (156)                   (130)                    (46)                     (34)  **

**Percent of Applications**** **

## Percent of R01 Applications Reviewed in AARR7 and AARR8  Study Sections Scoring 25th Percentile or Better(10/98 – 10/00 Councils)

**n=48**

**n=29**

**n=10**

**n=7**

**Total           (156)                   (130)                    (46)                     (34)  **

**Percent of Applications**** **

## Percent of NIDA R01 Applications Reviewed in “Patient-Oriented” Study Sections Scoring 15th Percentile or Better(10/99 – 10/00 Councils or 10/98 – 10/00 Councils*)

**n=8**

**n=3**

**n=3**

**n=4**

**Total         (77)                (13)                (32)                (17)                (45)**

**Percent of Applications**** **

**n=7**

## Percent of NIDA R01 Applications Reviewed in “Patient-Oriented” Study Sections Scoring 25th Percentile or Better(10/99 – 10/00 Councils or 10/98 – 10/00 Councils*)

**n=10**

**n=5**

**n=5**

**n=6**

**Total         (77)                (13)                (32)                (17)                (45)**

**Percent of Applications**** **

**n=13**

## Percent of NIDA R01 Applications Scoring 15th Percentile or 25th Percentile or Better in the Neuroscience and Behavioral and Social Science Study Sections (10/98 – 10/00 Councils)

**Percent of Applications**** **